A significant increase in the number of CD8 + T cells and 4-1BB expressing CD8 + T cells was detected in ATOR-1017 vs. isotype control treated mice in the tumor (Fig. 4i), but not in the spleen (Fig. 4j). This evidence concerns the gene CD8A and neoplasm.